On the contrary, NSD2 hyper-activation caused by either point mutations or genomic translocations represents a relevant cause of B-cell-associated hematological malignancies, such as multiple myeloma and acute leukemia, and other types of cancers including colon cancer and lung carcinoma [45,78,80,81,82]. This evidence concerns the gene NSD2 and lung carcinoma.